19.5.2021 16:15:00 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
The annual general meeting of Aqua Bio Technology ASA (the “Company”) will be held on 9 June 2021 at 10:00 (CEST) at Advokatfirmaet CLP DA, Sommerrogata 13-15, 0255 Oslo.
Attached is the notice of the annual general meeting together with attendance and proxy form, the board of directors’ statement on remuneration to senior management and the recommendation from the nomination committee.
All documents to be treated at the general meeting, including the Company’s annual accounts of 2020, will be made available at the Company’s website www.aquabiotechnology.com.
Due to the corona virus situation, the Company encourages the shareholders to refrain from attending the general meeting in person and to give authorization to vote the shares.
Shareholders who wish to attend the general meeting is requested to notify the Company as set out in the notice within 4 June 2021 at 16:00 (CEST). In case of attendance by proxy, the proxy form is requested submitted to be received by the Company within the same date.
For further information, please contact CEO Espen Kvale, telephone +47 9162 8092.
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT’s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company’s strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.
This information was considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
ABT Innkalling OGF 2021 Notice AGM 2021.pdf
ABT Paameldingsskjema og fullmakt OGF 2021 Registration Form and Proxy AGM 2021.pdf
ABT Nomination commitee proposal and Statement and remuneration to executive management.pdf
